Ono Pharmaceutical

(OTC) OPHLY

Current Price$4.70

Market Cap$6.63B

Since IPO (2012)+20%

5 Year-28%

1 Year+32%

1 Month-12%

Ono Pharmaceutical Financials at a Glance

Market Cap

$6.63B

Revenue (TTM)

¥522.75B

Net Income (TTM)

¥70.78B

EPS (TTM)

$0.33

P/E Ratio

14.19

Dividend

$0.09

Beta (Volatility)

0.23 (Low)

Dividend

$0.09

Beta (Volatility)

0.23 (Low)

Price

$4.70

Volume

36,163

Open

$4.59

Price

$4.70

Volume

36,163

Open

$4.59

Previous Close

$4.70

Daily Range

$4.59 - $4.97

52-Week Range

$3.35 - $5.75

Estimated Earnings Date

Aug 3, 2026

Dividend

$0.09

Beta (Volatility)

0.23 (Low)

Price

$4.70

Volume

36,163

Open

$4.59

Previous Close

$4.70

Daily Range

$4.59 - $4.97

52-Week Range

$3.35 - $5.75

Estimated Earnings Date

Aug 3, 2026

OPHLY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ono Pharmaceutical

Industry

Pharmaceuticals

Sector

Health Care

Employees

4,287

CEO

Gyo Sagara

Website

www.ono-pharma.com/ja

Headquarters

Osaka, 541-8564, JP

OPHLY Financials

Key Financial Metrics (TTM)

Gross Margin

73%

Operating Margin

20%

Net Income Margin

14%

Return on Equity

Return on Capital

11%

Return on Assets

Earnings Yield

7.05%

Dividend Yield

1.83%

Payout Ratio

53.80%

Stock Overview

Market Cap

$6.63B

Shares Outstanding

1.41B

Volume

36.16K

Avg. Volume

33.65K

Financials (TTM)

Gross Profit

¥396.63B

Operating Income

¥109.57B

EBITDA

¥149.60B

Operating Cash Flow

¥145.07B

Capital Expenditure

-¥6.39B

Free Cash Flow

¥138.69B

Cash & ST Invst.

¥238.13B

Total Debt

¥121.46B

Ono Pharmaceutical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2026YOY CHG

Revenue

¥120.93B

+7.7%

Gross Profit

¥87.26B

+30.1%

Gross Margin

72.16%

N/A

Market Cap

$6.63B

N/A

Market Cap/Employee

$1.72M

N/A

Employees

3,853

N/A

Net Income

¥833.03M

+112.7%

EBITDA

¥22.42B

+487.4%

Quarterly Fundamentals

Name

Q4 2026YOY CHG

Total Cash

¥238.13B

+13.2%

Total Debt

¥121.46B

-17.2%

Accounts Receivable

¥146.57B

+8.6%

Inventory

¥57.70B

-22.9%

Long Term Debt

¥82.83B

-27.0%

Short Term Debt

¥38.63B

+16.4%

Return on Assets

6.31%

N/A

Return on Invested Capital

10.96%

N/A

Free Cash Flow

¥49.80B

+32.5%

Operating Cash Flow

¥50.81B

+30.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

GZPHFGuangzhou Baiyunshan Pharmaceutical Holdings Company Limited

GZPHFGuangzhou Baiyunshan Pharmaceutical Holdings Company Limited$2.34+0.00%

KYKOFKyowa Kirin Co., Ltd.

KYKOFKyowa Kirin Co., Ltd.$14.43+0.00%

DSRLFDiaSorin S.p.A.

DSRLFDiaSorin S.p.A.$84.10+0.00%

HKMPYHikma Pharmaceuticals PLC

HKMPYHikma Pharmaceuticals PLC$40.51-0.02%

FLMNFFielmann AG

FLMNFFielmann AG$50.75+0.00%

HKMPFHikma Pharmaceuticals PLC

HKMPFHikma Pharmaceuticals PLC$19.29+0.00%

SNPHFSanten Pharmaceutical Co., Ltd.

SNPHFSanten Pharmaceutical Co., Ltd.$10.99+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

RKLBRocket Lab

RKLBRocket Lab$102.39-0.11%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.02-0.00%

ONDSOndas

ONDSOndas$9.33-0.05%

Questions About OPHLY

What is the current price of Ono Pharmaceutical?

Ono Pharmaceutical is trading at $4.70 per share.

What is the 52-week range for Ono Pharmaceutical?

Over the past 52 weeks, Ono Pharmaceutical has traded between $3.35 and $5.75.

How much debt does Ono Pharmaceutical have?

As of the most recent reporting period, Ono Pharmaceutical reported total debt of ¥760.17M.

How much cash does Ono Pharmaceutical have on hand?

Ono Pharmaceutical reported ¥1.49B in cash and cash equivalents in its most recent financial results.

What is Ono Pharmaceutical’s dividend yield?

Ono Pharmaceutical currently has a dividend yield of 1.83%.

Ono Pharmaceutical

Ono Pharmaceutical Financials at a Glance

OPHLY News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Ono Pharmaceutical

OPHLY Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Ono Pharmaceutical Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About OPHLY

What is the current price of Ono Pharmaceutical?

What is the 52-week range for Ono Pharmaceutical?

How much debt does Ono Pharmaceutical have?

How much cash does Ono Pharmaceutical have on hand?

What is Ono Pharmaceutical’s dividend yield?

Premium Investing Services